Musaffa Logo

Our certifications

Independent proof that every stock and portfolio meets halal standards.

How we screen every stock
METHODOLOGY

How we screen every stock

Our 5-step halal methodology, in 90 seconds.

BJDX Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: June 09, 2026

Report Source: 2026 1st Quarter Report

Analyst's Ratings for Bluejay Diagnostics Inc (BJDX)

Based on 6 analysts giving stock ratings to Bluejay Diagnostics Inc in the past 3 months

Strong
Sell
SellHoldBuyStrong
Buy
Strong Buy
0
Buy
0
Hold
50
Sell
17
Strong Sell
33
Bluejay Diagnostics Inc

Bluejay Diagnostics Inc. Stock Analysis BJDX

United States Health Care Nano Cap Report:
Bluejay Diagnostics, Inc. operates as a diagnostic company. The company is headquartered in Acton, Massachusetts and currently employs 6 full-time employees. The company went IPO on 2021-11-10. The company develops rapid tests using whole blood on its Symphony technology platform (Symphony), which consists of an analyzer and single-use protein detection cartridges that have the function of automatic stepwise feeding of reagent. The Symphony device is designed to produce laboratory-quality results in 20 minutes in critical care settings, including Intensive Care Units (ICUs) and Emergency Rooms (ERs). Its product candidate, the Symphony IL-6 test, is an immunoassay for the measurement of interleukin-6 (IL-6) to be used for the monitoring of disease progression in critical care settings. The company is focused on pursuing the Symphony IL-6 test in the context of sepsis. IL-6 is a clinically established inflammatory biomarker, and is considered a 'first-responder', for the assessment of severity of infection and inflammation across many disease indications, including sepsis.
Read More

Bluejay Diagnostics Inc (BJDX) Chart

Key Statistics of Bluejay Diagnostics Inc (BJDX)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$3.12$3.88

Today's Open

$3.84

Volume

39.93K

P/E Ratio (TTM)

-

52 Week Range

$1.62$16.68

Market Cap

2.02M

Avg. Volume

4.02M

Dividend Yield

-

Financial Metrics & Statements of Bluejay Diagnostics Inc (BJDX)

FAQ's for Bluejay Diagnostics Inc (BJDX)

  • According to Musaffa’s Shariah screening methodology, Bluejay Diagnostics Inc (BJDX) is currently classified as NOT HALAL as of June 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.
  • A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Bluejay Diagnostics Inc using these criteria to determine its compliance status.
  • Muslim investors may consider investing in Bluejay Diagnostics Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
  • Musaffa determines the Shariah status of Bluejay Diagnostics Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
  • The Shariah compliance status of Bluejay Diagnostics Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
  • Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
  • You can check the latest Shariah compliance status of Bluejay Diagnostics Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Disclaimer

The content provided on this website is intended solely for informational and educational purposes. Musaffa is a technology, data, education, and research company. We are not licensed financial service provider by the authorized relevant financial service regulator in India or any other regulatory government body, and we do not offer or facilitate any trading, brokerage, investment, or financial advisory services. We do not deliberately target an audience seeking financial services.

By accessing this website, you acknowledge and confirm that you are seeking information relating to Musaffa of your own accord, and that there has been no form of solicitation, advertisement, or inducement by Musaffa or its members. Musaffa shall not be liable for the consequences of any action taken by relying on the material or information provided on this website. The contents of this website are the intellectual property of Musaffa.